Ryan Cross
Senior Science Correspondent
Endpoints News
Ryan Cross is the Senior Science Correspondent at Endpoints News. He joined the newsroom in 2023 after covering biotech for The Boston Globe. Before that he was at Chemical & Engineering News where he led coverage of COVID vaccines, gene editing, and all things RNA. His work has also appeared in MIT Technology Review, Science, STAT, and more. Ryan is a graduate of Boston University's master's program in science journalism, and he studied genetics, neuroscience, and medicinal chemistry at Purdue University. He currently lives in Cambridge, Massachusetts. Reach out privately on Signal: RyanCross.25
Sessions
-
22-Jun-202631ABIn Vivo Hematopoietic Stem Cell Engineering for One-Time Genetic Medicines
-
23-Jun-202624BCNeuroinflammation – The Next Frontier in Alzheimer’s and Other Neurodegenerative Diseases
-
24-Jun-202631CTranslating Longevity Biology into Therapeutics for Age-Related Diseases
-
25-Jun-202624BCImmunotherapy’s Quiet Architects: From “Dreamers” to Pioneers of Modern Oncology
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}